PTGS2 and Miyoshi myopathy: These findings prompted us to investigate the level of COX-2 expression in MM and the relationship between the expression of this marker and prognostic factors in melanoma, including depth of invasion, tumor thickness, mitosis rate, lymphovascular invasion, lymphocyte infiltration, and tumor staging.